Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

Clinical trial NCT06751121 · COMPLETED

Trial details

NCT number: NCT06751121
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Helicobacter Pylori Infection Helicobacter Pylori Infected Patients Helicobacter Pylori Infected Subjects

Start date: 2024-02-06
Primary completion: 2025-04-24
Enrollment: 461

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.